Loading...
  • particles
  • A method of fabricating hydrogel particles within liposomes, which entails: a) encapsulating an effective amount of each of one or more hydrogel substances and one or more release agents in liposomes in a liquid medium, b) removing any unencapsulated hydrogel substances and release agents from the liquid. (google.co.uk)
  • 5. The hydrogel particles of claim 1, wherein said liposomes are unilamellar liposomes. (google.co.uk)
  • The present invention relates to a method for fabricating hydrogel particles having an accurately controlled size using liposomes. (google.co.uk)
  • 9 . The process according to claim 1 , characterised in that the carrier particles, especially liposomes, have a substantially uniform size in the range between about 1 and about 50 μm, preferably in the range between about 1 and about 30 μm. (google.es)
  • 10 . The process according to claim 9 , characterised in that the carrier particles, especially liposomes, have a substantially uniform size in the range between about 20 and 30 μm diameter for application to the trachea, in the range between about 10 and 20 μm diameter for application to the bronchi and between about 1 and 6 nm, especially between 2 and 5 μm, diameter for application to the alveoli. (google.es)
  • proteins
  • Examples of liposome-based IVC for screening proteins such as GFP and β -glucuronidase are described. (hindawi.com)
  • If this phase of the project proceeds well then we will look to assemble FtsZ on the inside of liposomes and probe its interaction with other proteins involved in the formation of the Z-ring. (warwick.ac.uk)
  • relatively
  • Once in the tumor interstitial space, liposomes, because of their relatively large size, tend to reside preferentially in the perivascular space just outside the blood vessels and do not become homogeneously distributed throughout the tumor. (aacrjournals.org)
  • The great structural versatility of liposomes, their relatively inoccuous nature and ability to incorporate a wide spectrum of biologically active agents have led to the adoption of the system by numerous workers as a drug carrier. (springer.com)
  • method
  • Tumor volume ranged from 1.2 to 236.2 cm 3 , and thermal dose ranged from 2.0 to 243.3 CEM43CT90 (equivalent time that the 10th percentile temperature was equal to 43°C). There was not a relationship between either tumor volume or hyperthermia dose on the magnitude of increased liposome accumulation, suggesting that this method has application across a range of tumor volumes and degrees of heatibility. (aacrjournals.org)
  • release
  • 11. The composition of claim 3, wherein the surfactant causes an increase in drug release rate from the liposomes of about 5% to 50% as measured by an IVR assay. (freepatentsonline.com)
  • The data are consistent with paclitaxel release from circulating liposomes, but with efflux delayed sufficiently to retain drug to a greater extent in the central (blood) compartment and reduce penetration into peripheral tissues. (pubmedcentralcanada.ca)
  • agents
  • Liposomes have been used in a variety of commercial applications, and for encapsulating a variety of different agents therein. (google.co.uk)
  • route
  • These pores are heterogeneously distributed throughout the tumor vasculature and provide a heterogeneous route for liposome accumulation into the tumor extravascular tissue. (aacrjournals.org)
  • results
  • Our results show that liposomes and chromaffin granules fuse with GUVs containing activated SNAREs with only few milliseconds delay between docking and fusion. (mpg.de)
  • least
  • 3 . The process according to claim 1 , characterised in that at least the greatest part of said agent is encapsulated inside the carrier, especially a liposome or microsphere carrier. (google.es)
  • system
  • On T1-weighted images, both liposome preparations gave a strong signal enhancement of the organs of the mononuclear phagocyte system (MPS). (uzh.ch)
  • 2 In parallel, there has been considerable progress in liposome technology 1 and related achievements have ensured in many cases adoption of the liposome system by the Industry. (springer.com)